When is a scientific study not a scientific study? That was a question posed by several panelists during a two-hour session on medication Jan. 25 during the National HBPA winter convention.
The New York Gaming Commission, during a Jan. 21 public hearing, heard the pros and cons of having different medication rules for Thoroughbred and Standardbred racehorses.
- By Tom LaMarra
An official with the RMTC said confidentiality agreements used when the organization considers research to set thresholds and withdrawal times for medications are necessary because of scientific factors.
Regulatory administration of race-day anti-bleeding medication in Kentucky has provided a clearer picture of drug testing and produced added security benefits, officials said.
The Racing Medication and Testing Consortium board of directors has approved thresholds and withdrawal guidelines for six medications that have been identified as having therapeutic purposes.
The Racing Medication and Testing Consortium has hired Dr. Dionne Benson as executive director and chief operating officer.
Most Popular Stories
- California Chrome Returning Early From Break
- The Pizza Man Key Ingredient To Arlington
- Wise Dan Turns in First Breeze Since Surgery
- Multiple Group I Winner The Fugue Retired
- The Influence of His Majesty
- Jockey Stevens to Undergo Knee Surgery
- Tattersalls July Sale Ends on High Note
- French Derby Duo Clash Again at Longchamp
- Belmont to Offer Low-Roller Player Tourney
- AHC: Bonus Depreciation Bill Passed by House